(Q28168691)

4

object named as

Dimitri P Mikhailidis

0 references

author name string

I Anita Jagroop

1

0 references

Miltiadis I Matsagas

2

0 references

George Geroulakos

Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs

3

0 references

language of work or name

English

0 references

publication date

March 2004

0 references

published in

Platelets

0 references

volume

15

0 references

issue

2

0 references

page(s)

117-25

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080/09537105310001645960

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

ADP-induced platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Pharmacological control of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Identification, characterization, and inhibition of the platelet ADP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

The role of platelets in peripheral arterial disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

A low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Blood platelet count and function are related to total and cardiovascular death in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Adhesive interactions in hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Role of inflammatory mediators in thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Antiplatelet therapy in peripheral arterial disease. Consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537105310001645960

10.1080/09537105310001645960

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_r6ngjqbbo5dbdlltindsgucope

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r6ngjqbbo5dbdlltindsgucope